Clinical Trials Logo

Clinical Trial Summary

Liposomal bupivacaine (Exparel) has been used as an adjunct to pain management in the perioperative setting. However, the efficacy of the drug has not bewen studied in patients with benign soft tissue tumor resections. The goal of the study is to see if Exparel controls pain and improves functional outcomes for patients after these procedures compared to the current standard Bupivacaine HCL.


Clinical Trial Description

Liposomal bupivacaine (Exparel) has been used as an adjunct to pain management in the perioperative setting. However, the efficacy of the drug has not bewen studied in patients with benign soft tissue tumor resections. The goal of the study is to see if Exparel controls pain and improves functional outcomes for patients after these procedures compared to the current standard Bupivacaine HCL. Patients will be randomly assigned Exparel or Bupivacaine HCL intraoperatively during the tumor resection. The amount administered is based on the size of wound after tumor resection. The patients are then provided a pain diary in which they record the amount of pain medications taken, VAS pain scores, and musculoskeletal and tumor society score (MSTS) for the first week postoperatively. The study will end once 140 patients have been enrolled. Data will be analyzed comparing morphine equivalents, pain scores, and functional scores between the groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05082441
Study type Interventional
Source Samaritan Health Services
Contact
Status Recruiting
Phase Phase 4
Start date September 1, 2020
Completion date September 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05726136 - Fluid Challenge and Plasma Volume, During Surgery Phase 4
Completed NCT01817075 - Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Phase 3
Recruiting NCT04752137 - Intraoperative Tumor Margin Identification With ICG Dye Imaging Phase 2
Active, not recruiting NCT01993199 - Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors N/A
Enrolling by invitation NCT05041608 - Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Recruiting NCT06174532 - Virtual Surgical Planning in Mandibular Segmental Resection N/A
Completed NCT04360993 - Role of PET/MRI in Head and Neck Cancer
Available NCT03626285 - Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders